Skin eruptions have been reported with the use of all antiepileptic drugs and there is a significant risk of cross-reactivity between these agents in causing serious eruptions such as Stevens-Johnson's syndrome. Gabepentin is usually considered a safe agent for patients with a previous history of drug allergies and there have been no cases of skin eruption reported to the gabapentin post marketing surveillance. We report a patient who had severe Stevens-Johnson's syndrome induced by phenytoin and later by carbamazepine. Subsequent use of gabapentin also resulted in a skin eruption which was limited to the lower extremities but without systemic or mucosal involvement. This case suggests that patients with a strong history of drug-induced idiosyncratic reactions may experience such reactions to gabapentin as well.

Download full-text PDF

Source
http://dx.doi.org/10.1097/00007691-199902000-00022DOI Listing

Publication Analysis

Top Keywords

skin eruption
12
stevens-johnson's syndrome
12
skin
4
gabapentin
4
eruption gabapentin
4
gabapentin patient
4
patient repeated
4
repeated aed-induced
4
aed-induced stevens-johnson's
4
syndrome skin
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!